601
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the anti-inflammatory activity of N, N′-bis(3-dimethylamino-1-phenyl-propylidene)hydrazine dihydrochloride

, &
Pages 968-972 | Received 17 Mar 2008, Accepted 25 Aug 2008, Published online: 17 Aug 2009

References

  • Carnevale KA, Cathcart MK (2001): Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1. J Immunol 167: 3414–3421.
  • Chand N, Pillar J, Diamantis W, Sofia RD (1985): In vitro inhibition of allergic histamine release by calcium antagonists. Eur J Pharmacol 107: 353–358.
  • Dauksas V, Gaidelis P, Udrenaite E, Labanauskas L, Gumbaragyte L, Gasperaviciene G, Ramanauskas D (1990): Synthesis and antiinflammatory activity of structural analogs and metabolites of 5-(3-dimethylaminopropionyl)-1,3-benzodioxolane. Khimiko-Farmatsevticheskii Zhurnal 24: 50–52. [in Russian]
  • El-Bizri N, Bkaily G, Wang S, Jacques D, Regoli D, D’Orleans-Juste P, Sukarieh R (2003): Bradykinin induces a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells. Can J Physiol Pharmacol 81: 247–258.
  • El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S, Arbid MS (2002): Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res 46: 235–243.
  • Godfraind T, Miller R, Wibo M (1986): Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321–416.
  • Gul HI, Gul M, Vepsalainen J, Erciyas E, Hanninen O (2003): Cytotoxicity of some azines of acetophenone derived mono-Mannich bases against Jurkat cells. Biol Pharm Bull 26: 631–637.
  • Gupta M, Mazumdar UK, Sivakumar T, Vamsi ML, Karki SS, Sambathkumar R, Manikandan L (2003): Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. Biol Pharm Bull 26: 1342–1344.
  • Honda Z, Ishii S, Shimizu T (2002): Platelet-activating factor receptor. J Biochem (Tokyo) 131: 773–779.
  • Houck JC, Chang CM (1979): Permeability factor contaminating hyaluronidase preparations. Inflammation 3: 447–451.
  • Leslie CC (1997): Properties and regulation of cytosolic phospholipase A2. J Biol Chem 272: 16709–16712.
  • Marzocco S, Paola RD, Serraino I, Sorrentino R, Meli R, Mattaceraso G, Cuzzocrea S, Pinto A, Autore G (2004): Effect of methylguanidine in carrageenan-induced acute inflammation in the rat. Eur J Pharmacol 484: 341–350.
  • Nacife VP, Mde NS, Gomes RN, D’Avila H, Neto HCC-F, Mde NM (2004): Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Funct 29: 27–34.
  • Procida C, Mantovani V, Bianchini P (1971): Anti-hyaluronidase activity of some pyrazole derivatives. Boll Soc Ital Biol Sper 47: 159–163.
  • Suleyman H, Demirezer LO, Kuruuzum A, Buyukokuroglu ME, Gocer F, Banoglu ZN, Gepdiremen A (2001): Effect of the aqueous extract of Rumex patientia on xylol and hyaluronidase induced capillary permeability compared to indomethacin. Pharmazie 56: 92–93.
  • Suleyman H, Gul HI, Asoglu M (2003): Antiinflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride. Pharmacol Res 47: 471–475.
  • Suleyman H, Gul HI, Gul M, Alkan M, Gocer F (2007): Anti-inflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat. Biol Pharm Bull 30: 63–67.
  • Weissmann G (1993): Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediat 6: 275–286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.